Download PDF
CC BY 4.0 · Journal of Child Science 2020; 10(01): e202-e206
DOI: 10.1055/s-0040-1720956
Original Article

Clinical and Genetic Varieties of Gaucher Disease in Iraqi Children

Mohammad Fadhil Ibraheem
1   Department of Pediatrics, College of Medicine, University of Baghdad, Baghdad, Iraq
,
Shaymaa Jamal Ahmed
2   Department of Anatomy, College of Medicine, University of Baghdad, Iraq
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Gaucher disease (GD), which is due to a deficiency in the lysosomal enzyme β-glucocerebrosidase, is a rare genetic disorder. It is characterized by a wide variety of clinical manifestations and severity of symptoms, making it difficult to manage. A cross-sectional hospital-based genetic study was undertaken with 32 pediatric patients. We recruited 21 males and 11 females diagnosed with GD, with a male-to-female ratio of 1.91:1. The mean age of the study population was 8.79 ± 4.37 years with an age range from 8 months to 17 years. We included patients on clinical evaluation from 2011 to 2019. An enzyme assay test was used to measure β-glucosidase enzyme activity in leukocytes and the GBA gene study was performed by polymerase chain reaction technique. We found GD type 1 in 27 (84.37%) participants, GD type 3 in five (15.63%) participants, while none classified as GD type 2. The dominant mutation in GD 1 was N370S in 81.5%, of which two-thirds were homozygous. The second common mutation in this type of disease (L444P) was present in nine cases (40.9%), two of whom were homozygous (9.9%). Meanwhile, R463C was present in six cases (27.27%), of whom one was homozygous. In GD 3, the dominant mutation was L444P as seen in 80% of the patients followed by N370S and R463C in 20%. This study shows that the most common mutant allele in this study was N370S, followed by L444P. Further large-scale studies with more advanced designs are recommended to explore the sequences of GBA genes.

Keywords

Gaucher disease - N370S - L444P - R463C - GBA genes


Publication History

Received: 15 July 2020

Accepted: 05 October 2020

Article published online:
19 November 2020

© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).

Georg Thieme Verlag KG
Stuttgart · New York

 

  • References

  • 1 Mistry PK, Belmatoug N, vom Dahl S, Giugliani R. Understanding the natural history of Gaucher disease. Am J Hematol 2015; 90 (Suppl. 01) S6-S11
    CrossrefPubMedGoogle Scholar
  • 2 Deegan PB, Cox TM. Imiglucerase in the treatment of Gaucher disease: a history and perspective. Drug Des Devel Ther 2012; 6: 81-106
    PubMedGoogle Scholar
  • 3 Nalysnyk L, Rotella P, Simeone JC, Hamed A, Weinreb N. Gaucher disease epidemiology and natural history: a comprehensive review of the literature. Hematology 2017; 22 (02) 65-73
    CrossrefPubMedGoogle Scholar
  • 4 Essabar L, Meskini T, Lamalmi N, Ettair S, Erreimi N, Mouane N. Gaucher's disease: report of 11 cases with review of literature. Pan Afr Med J 2015; 20: 18
    PubMedGoogle Scholar
  • 5 Weinreb NJ, Goldblatt J, Villalobos J. et al. Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment. J Inherit Metab Dis 2013; 36 (03) 543-553
    CrossrefPubMedGoogle Scholar
  • 6 Razek AA, Abdalla A, Fathy A, Megahed A. Apparent diffusion coefficient of the vertebral bone marrow in children with Gaucher's disease type I and III. Skeletal Radiol 2013; 42 (02) 283-287
    CrossrefPubMedGoogle Scholar
  • 7 Hruska KS, LaMarca ME, Scott CR, Sidransky E. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat 2008; 29 (05) 567-583
    CrossrefPubMedGoogle Scholar
  • 8 Beutler E, Gelbart T. Hematologically important mutations: Gaucher disease. Blood Cells Mol Dis 1997; 23 (01) 2-7
    CrossrefPubMedGoogle Scholar
  • 9 Vanier MT, Caillaud C. Disorders of sphingolipid metabolism and neuronal ceroid-lipofuscinoses. . In: Saudubray JM, Berghe G, Walter JH. , eds. Inborn Metabolic Diseases Diagnosis and Treatment. 5th ed. Berlin Heidelberg: Springer-Verlag; 2012: 557-559
    Google Scholar
  • 10 Goker-Alpan O, Hruska KS, Orvisky E. et al. Divergent phenotypes in Gaucher disease implicate the role of modifiers. J Med Genet 2005; 42 (06) e37
    CrossrefPubMedGoogle Scholar
  • 11 Vellodi A, Tylki-Szymanska A, Davies EH. et al. Management of neuronopathic Gaucher disease: revised recommendations. J Inherit Metab Dis 2009; 32 (05) 660-664
    CrossrefPubMedGoogle Scholar
  • 12 Bellomo-Brandão MA, Costa-Pinto EA, De Tommaso AM, Hessel G. Clinical and biochemical features of autoimmune hepatitis in 36 pediatric patients. Arq Gastroenterol 2006; 43 (01) 45-49
    CrossrefPubMedGoogle Scholar
  • 13 Zimran A, Kay A, Gelbart T. et al. Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients. Medicine (Baltimore) 1992; 71 (06) 337-353
    CrossrefPubMedGoogle Scholar
  • 14 Burrow TA, Barnes S, Grabowski G. Prevalence and management of Gaucher disease. Pediatric Health Med Ther 2011; 2: 59-73
    PubMedGoogle Scholar
  • 15 Oliveira MC, Oliveira BM, Queirós E, Viana MB. Clinical and nutritional aspects of Gaucher disease: prospective study of 13 children at a single center. J Pediatr (Rio J) 2002; 78 (06) 517-522
    CrossrefPubMedGoogle Scholar
  • 16 Tantawy AAG, Sherif EM, Adly AAM, Hassanine S, Awad AH. Evoked potentials and neurocognitive functions in pediatric Egyptian Gaucher patients on enzyme replacement therapy: a single center experience. J Inherit Metab Dis 2013; 36 (06) 1025-1037
    CrossrefPubMedGoogle Scholar
  • 17 Alasmar D. Gaucher disease in Syrian children: common mutations identification, and clinical futures. Ann Saudi Med 2015; 35 (02) 127-132
    CrossrefPubMedGoogle Scholar
  • 18 Erdemır G, Özkan T, Özgür T, Yazici Z, Özdemır Ö. Pediatric Gaucher experience in South Marmara region of Turkey. Turk J Gastroenterol 2011; 22 (05) 500-504
    CrossrefPubMedGoogle Scholar
  • 19 Charrow J, Andersson HC, Kaplan P. et al. The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med 2000; 160 (18) 2835-2843
    CrossrefPubMedGoogle Scholar
  • 20 Elgawhary S, Ghaffar HA, Eid K, Wahab MA, Ragab WS, Saleh WF. Prenatal genotyping of Gaucher disease in Egypt. Egypt J Med Hum Genet 2013; 14 (04) 361-365
    CrossrefPubMedGoogle Scholar
  • 21 Kaplan P, Andersson HC, Kacena KA, Yee JD. The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis. Arch Pediatr Adolesc Med 2006; 160 (06) 603-608
    CrossrefPubMedGoogle Scholar
  • 22 Saleem TH, Hassan MH, El-Abd Ahmed A. et al. Clinical and genetic assessment of pediatric patients with Gaucher's disease in Upper Egypt. Egypt J Med Hum Genet 2017; 18: 249-255
    CrossrefPubMedGoogle Scholar
  • 23 Shehi B, Boçari G, Vyshka G, Xhepa R, Alushani D. Gaucher's disease in Albanian children: casuistics and treatment. Iran J Pediatr 2011; 21 (01) 1-7
    PubMedGoogle Scholar
  • 24 Razek AAKA, Abdalla A, Barakat T, El-Taher H, Ali K. Multi-parametric MR imaging using apparent diffusion coefficient and fat fraction in quantification of bone marrow in pediatrics with Gaucher disease. Clin Imaging 2018; 51: 318-322
    CrossrefPubMedGoogle Scholar
  • 25 Krasnewich DM, Sidransky E. Gaucher disease. Goldman-Cecil medicine. In: Goldman L, Schafer AI. , eds. 26th ed.. Philadelphia: Kennedy JF; 2020: 1369-1370
    Google Scholar
  • 26 Emre S, Gürakan F, Yüce A, Rolf A, Scott R, Ozen H. Molecular analysis of Turkish Gaucher disease patients: identification of novel mutations in glucocerebrosidase (GBA) gene. Eur J Med Genet 2008; 51 (04) 315-321
    CrossrefPubMedGoogle Scholar
  • 27 Elmonem MA, Mahmoud IG, Mehaney DA. et al. Lysosomal storage disorders in Egyptian children. Indian J Pediatr 2016; 83 (08) 805-813
    CrossrefPubMedGoogle Scholar
  • 28 Giraldo P, Alfonso P, Irún P. et al. Mapping the genetic and clinical characteristics of Gaucher disease in the Iberian Peninsula. Orphanet J Rare Dis 2012; 7 (17) 17
    CrossrefPubMedGoogle Scholar
  • 29 Lee J-Y, Lee BH, Kim G-H. et al. Clinical and genetic characteristics of Gaucher disease according to phenotypic subgroups. Korean J Pediatr 2012; 55 (02) 48-53
    CrossrefPubMedGoogle Scholar
  • 30 Schwartz IVD, Göker-Alpan Ö, Kishnani PS. , et al; GOS Study group. Characteristics of 26 patients with type 3 Gaucher disease: a descriptive analysis from the Gaucher outcome survey. Mol Genet Metab Rep 2017; 14: 73-79
    CrossrefPubMedGoogle Scholar